Sinusoidal obstruction syndrome classification: Difference between revisions
Line 10: | Line 10: | ||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="1" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" + | | ! colspan="1" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" + |Parameters | ||
! colspan="1" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" + | | ! colspan="1" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" + |Mild | ||
! colspan="1" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" + | | ! colspan="1" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" + |Moderate | ||
! colspan="1" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" + | | ! colspan="1" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" + |Severe | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" + | | | align="center" style="background:#DCDCDC;" + |Serum total bilirubin | ||
| | | | ||
* | * <5 mg/dL | ||
| | | | ||
* < | * < (5.1 to 8 mg/dL | ||
| | | | ||
* > | * >8 mg/dL | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" + | | | align="center" style="background:#DCDCDC;" + |Serum aspartate aminotransferase (AST) | ||
| | | | ||
* [[Blood]] [[pH]] | * [[Blood]] [[pH]] | ||
Line 31: | Line 31: | ||
* > 7.30 | * > 7.30 | ||
|- | |- | ||
| colspan="1" rowspan="1" align="center" style="background:#DCDCDC;" + |[[Anion gap]] | | colspan="1" rowspan="1" align="center" style="background:#DCDCDC;" + |[[Anion gap|Weight above baseline]] | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" | | ||
* (Na<sup>+</sup>) – (Cl<sup>–</sup> + HCO3<sup>–</sup>) | * (Na<sup>+</sup>) – (Cl<sup>–</sup> + HCO3<sup>–</sup>) | ||
Line 39: | Line 39: | ||
* Variable | * Variable | ||
|- | |- | ||
| colspan="1" rowspan="1" align="center" style="background:#DCDCDC;" + |[[Osmolality|Serum | | colspan="1" rowspan="1" align="center" style="background:#DCDCDC;" + |[[Osmolality|Serum creatinine]] | ||
| colspan="1" rowspan="1" | | | colspan="1" rowspan="1" | | ||
* 2([[Sodium|Na]] + [[Potassium|K]]) + ([[glucose]]/18) + ([[blood]] [[urea]] [[nitrogen]]/2.8) | * 2([[Sodium|Na]] + [[Potassium|K]]) + ([[glucose]]/18) + ([[blood]] [[urea]] [[nitrogen]]/2.8) | ||
Line 46: | Line 46: | ||
| | | | ||
* Increased (> 320mOsm/kg) | * Increased (> 320mOsm/kg) | ||
|} | |} | ||
Revision as of 06:22, 5 February 2018
Sinusoidal obstruction syndrome Microchapters |
Differentiating Sinusoidal obstruction syndrome from Other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Sinusoidal obstruction syndrome classification On the Web |
American Roentgen Ray Society Images of Sinusoidal obstruction syndrome classification |
Directions to Hospitals Treating Sinusoidal obstruction syndrome |
Risk calculators and risk factors for Sinusoidal obstruction syndrome classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is no established system for the classification of sinusoidal obstruction syndrome.
Classification
There is no established system for the classification of sinusoidal obstruction syndrome. However, it can be classified on the basis of severity as mild, moderate and sever.
Parameters | Mild | Moderate | Severe |
---|---|---|---|
Serum total bilirubin |
|
|
|
Serum aspartate aminotransferase (AST) |
|
| |
Weight above baseline |
|
|
|
Serum creatinine |
|
|